AP NEWS
Press release content from BusinessWire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from BusinessWire
Press release content from BusinessWire. The AP news staff was not involved in its creation.

Aphena Names Shawn Reilley New CEO

December 11, 2018

EASTON, Md.--(BUSINESS WIRE)--Dec 11, 2018--Aphena Pharma Solutions Inc. announced Dec. 1 that the active CEO, Kevin Kerchner, is retiring and that the board of directors has hired Shawn Reilley to take over as the new CEO of the pharmaceutical packaging and manufacturing company.

“Under Kevin’s leadership, working with Aphena’s management team and our employees, the company has established a strong financial foundation,” said Matthew Thompson, board member at Aphena and principal at Enhanced Healthcare Partners. “And now, under Shawn Reilley’s leadership, we are excited to continue to invest in the business and build toward an exciting future.”

After an extensive search, Aphena’s board identified Reilley as an ideal candidate to lead the company on a continued growth path. Reilley has a bachelor’s degree and an MBA in finance from Miami University in Oxford, Ohio, and brings a strong executive and sales background to Aphena from the pharmaceutical packaging industry.

Reilley was president of Anderson Brecon (formerly Anderson Packaging), an industry-leading contract packaging company.

“Shawn’s experience with Anderson Packaging and leading such a regulated, pharmaceutical contract organization as Anderson will serve Aphena well moving forward,” said Thompson.

“I’m excited to join Aphena at this pivotal point in the company’s history,” said Reilley. “It is a privilege to be part of a company that is so committed to exceeding customer expectations through quality-driven systems. I’m looking forward to leading Aphena through its next phase of innovation and growth.”

Aphena Pharma Solutions Inc. is an industry-leading organization providing turnkey contract packaging and manufacturing solutions for the pharmaceutical, consumer health and medical device markets. With two separate FDA- and DEA-registered sites in the U.S., Aphena handles solid dose, liquids, gels, creams, ointments, foams, suspensions and lotions.

View source version on businesswire.com:https://www.businesswire.com/news/home/20181211005020/en/

CONTACT: Aphena Pharma Solutions Inc.

Eric Allen, 1-866-465-4506

eallen@aphenapharma.com

KEYWORD: UNITED STATES NORTH AMERICA MARYLAND

INDUSTRY KEYWORD: HEALTH MEDICAL DEVICES PHARMACEUTICAL MANUFACTURING PACKAGING

SOURCE: Aphena Pharma Solutions Inc.

Copyright Business Wire 2018.

PUB: 12/11/2018 10:00 AM/DISC: 12/11/2018 10:01 AM

http://www.businesswire.com/news/home/20181211005020/en